Booking Time 15:59:36
Sample Drawn: 30/09/2024 17:15:27
Sample Received: 30/09/2024 17:15:28
Print Date & Time: 02/10/2024 15:25:11
Date: 30/09/2024 Patient ID: 102459186 Refd by Lab:
Name : MRS. SONAM MAYANK JAIN Age : Sex: Female
Ref. By: WOMENS HOSPITAL
Sample Type: Urine,SERUM,EDTA,Flouride Random
Investigation : C.B.C.,COLLECTION,HbA1C,SUGAR RANDOM,TSH,URINE R/E
Test Name Value Unit Biological Ref Interval
HAEMATOLOGY
COMPLETE BLOOD COUNT
HAEMOGLOBIN (Hb) 13.3 gm/dl 12.0 - 15.0
Method: Non Cyanide.
TLC (Total Leucocyte Count ) 11710 /cu mm 4000 - 10000
Method: DC Detection
DIFFERENTIAL LEUCOCYTE COUNT
Method: Method: Flowcytometry / Microscopy
NEUTROPHILS 77 % 45 - 70
Method: Flow cytometry / Microscopy
LYMPHOCYTES 17 % 20 - 45
Method: Flow cytometry / Microscopy
MONOCYTES 03 % 00 - 10
Method: Flow cytometry / Microscopy
EOSINOPHILS 03 % 01 - 06
Method: Flow cytometry / Microscopy
R B C (Red Blood Cell Count) 4.48 Millions/cm m 3.80 - 4.80
Method: DC Detection
PCV / HCt (Hematocrit) 38.0 % 36.0 - 46.0
Method: Electrical Impedance
M C V (Mean Corp Volume) 84.8 Femtoliter 82.0 - 101.0
Method: Calculated.
M C H (Mean Corp Hb) 29.7 Picogram 27.0 - 32.0
Method: Calculated
M C H C (Mean Corp Hb Conc) 35.0 gm/dl 31.5 - 34.5
Method: Calculated.
PLATELET COUNT 287 X10³/µL 150 - 450
Method: DC Detection & Microscopy
Page No: 1 of 7
.
Booking Time 15:59:36
Sample Drawn: 30/09/2024 17:15:27
Sample Received: 30/09/2024 17:15:28
Print Date & Time: 02/10/2024 15:25:11
Date: 30/09/2024 Patient ID: 102459186 Refd by Lab:
Name : MRS. SONAM MAYANK JAIN Age : Sex: Female
Ref. By: WOMENS HOSPITAL
Sample Type: Urine,SERUM,EDTA,Flouride Random
Investigation : C.B.C.,COLLECTION,HbA1C,SUGAR RANDOM,TSH,URINE R/E
Test Name Value Unit Biological Ref Interval
RDW-SD 39.4 fl
Method: Calculated
RDW-CV 12.8 % 11.6 - 14.0
Method: Calculated
PDW 13.1 fl 10.0 - 17.9
Method: Calculated
MPV 11.1 fl 6.5 - 12.0
Method: Calculated
P-LCR 33.3 % 11.0 - 45.0
Method: Calculated
ABSOLUTE NEUTROPHIL COUNT 9.02 X10³/µL 2.00 - 7.00
Method: Calculated
ABSOLUTE LYMPHOCYTE COUNT 1.99 X10³/µL 1.00 - 3.00
Method: Calculated
ABSOLUTE MONOCYTE COUNT 0.35 X10³/µL 0.20 - 1.00
Method: Calculated
ABSOLUTE EOSINOPHIL COUNT 0.35 X10³/µL 0.04 - 0.44
Method: Microscopy
Page No: 2 of 7
.
Booking Time 15:59:36
Sample Drawn: 30/09/2024 17:15:27
Sample Received: 30/09/2024 17:15:28
Print Date & Time: 02/10/2024 15:25:11
Date: 30/09/2024 Patient ID: 102459186 Refd by Lab:
Name : MRS. SONAM MAYANK JAIN Age : Sex: Female
Ref. By: WOMENS HOSPITAL
Sample Type: Urine,SERUM,EDTA,Flouride Random
Investigation : C.B.C.,COLLECTION,HbA1C,SUGAR RANDOM,TSH,URINE R/E
Test Name Value Unit Biological Ref Interval
HAEMATOLOGY
GLYCOSYLATED HAEMOGLOBIN (HbA1c)
GLYCOSYLATED HAEMOGLOBIN (HbA1c) 5.50 % .
Non Diabetic : <6.00
Good Control : 6.00 - 7.00
Fair Control : 7.00 - 8.00
Poor Control : >8.00
ESTIMATED AVERAGE GLUCOSE (eAG) 111.15 mg/dl 65.00 - 135.00
REMARKS :
In vitro quantititative determination of HbA1c in whole blood is utilized in long term monitoring of glycemia.
The HbA1c lvevel correlates with the mean glucose concentration prevailing in the course of the patient's
recent history (apporx - 8-12 weeks) and therefore provides much more reliable information for glycemia
monitoring than determination of blood glucose or urinary glocose.
It is recommended that the determination of HbA1c be performed at intervals of 3-6 months during diabetes
mellitus therapy. Results of HbA1c should be assessed in conjunction with the patient's medical history,
clinical examinations and other findings.
Estimated average glucose (eAG) - There is a predictable relationship between HbA1c and eAG. It
helps people with diabetes to correlate their A1c to daily glucose monitoring levels. It reflects the
average glucose levels in the past 2-3 months. The eAG calculation convets the A1c percentage to
the same units used by glucometers mg/dl. The following table shows the relationship of eAG and A1c.
HbA1c eAG (mg/dl
5 97
6 126
7 154
8 183
9 212
10 240
11 269
12 298
.
Page No: 3 of 7
.
Booking Time 15:59:36
Sample Drawn: 30/09/2024 17:15:27
Sample Received: 30/09/2024 17:15:28
Print Date & Time: 02/10/2024 15:25:11
Date: 30/09/2024 Patient ID: 102459186 Refd by Lab:
Name : MRS. SONAM MAYANK JAIN Age : Sex: Female
Ref. By: WOMENS HOSPITAL
Sample Type: Urine,SERUM,EDTA,Flouride Random
Investigation : C.B.C.,COLLECTION,HbA1C,SUGAR RANDOM,TSH,URINE R/E
Test Name Value Unit Biological Ref Interval
BIOCHEMISTRY
BLOOD GLUCOSE RANDOM 84.20 mg/dl 70.00 - 170.00
Method: Hexokinase
Page No: 4 of 7
.
Booking Time 15:59:36
Sample Drawn: 30/09/2024 17:15:27
Sample Received: 30/09/2024 17:15:28
Print Date & Time: 02/10/2024 15:25:11
Date: 30/09/2024 Patient ID: 102459186 Refd by Lab:
Name : MRS. SONAM MAYANK JAIN Age : Sex: Female
Ref. By: WOMENS HOSPITAL
Sample Type: Urine,SERUM,EDTA,Flouride Random
Investigation : C.B.C.,COLLECTION,HbA1C,SUGAR RANDOM,TSH,URINE R/E
Test Name Value Unit Biological Ref Interval
ENDOCRINOLOGY
THYROID STIMULATING HORMONE (TSH) 1.48 uIU/mL 0.27 - 5.50
.
Adults > 20 Yrs : 0.270 - 5.500
Children
1-3 Days : 5.17 - 14.6
4 - 30 Days : 0.43 - 16.1
2 -12 Months : 0.62 - 8.05
2 - 6 Yrs : 0.54 - 4.53
7 - 11Yrs : 0.66 - 4.14
12 - 19 Yrs : 0.53 - 3.59
The new recommendations for TSH levels during pregnancy are the following:
First trimester: less than 2.5 with a range of 0.1-2.5.
Second trimester: 0.2-3.0
Note : TSH levels are subject to circadian variation, reaching peak levels between 2-4 am and at a minimum 6-10 pm
The variation is of the order of 50%, hence time of the day has influence on the meaured TSH concentrations.
.
Page No: 5 of 7
.
Booking Time 15:59:36
Sample Drawn: 30/09/2024 17:15:27
Sample Received: 30/09/2024 17:15:28
Print Date & Time: 02/10/2024 15:25:11
Date: 30/09/2024 Patient ID: 102459186 Refd by Lab:
Name : MRS. SONAM MAYANK JAIN Age : Sex: Female
Ref. By: WOMENS HOSPITAL
Sample Type: Urine,SERUM,EDTA,Flouride Random
Investigation : C.B.C.,COLLECTION,HbA1C,SUGAR RANDOM,TSH,URINE R/E
Test Name Value Unit Biological Ref Interval
URINE EXAMINATION REPORT
PHYSICAL
COLOUR YELLOW Pale Yellow
Method: Visual
TRANSPARENCY CLEAR Clear
Method: Visual
SPECIFIC GRAVITY 1.030 1.001 - 1.030
Method: Change in pKa
PH 5.0 5.0 - 8.0
Method: pH paper
DEPOSIT ABSENT Absent
Method: Manual Visiual
BIOCHEMICAL
ALBUMIN TRACE Nil
Method: Heat Coagulation
SUGAR NIL Nil
Method: Benedict's
BILE SALTS (BS) ABSENT Absent
Method: Hay's sulphur
BILE PIGMENT (BP) ABSENT Absent
Method: Fouchet's
MICROSCOPIC
PUS CELLS 6-8 /HPF 0-5
Method: Microscopy
EPITHELIAL CELLS 4-6 /HPF 0-5
Method: Microscopy
RBC'S NIL /HPF 0-2
Method: Microscopy
CASTS ABSENT Absent
Method: Microscopy
CRYSTALS NIL Nil
Method: Microscopy
BACTERIA ABSENT ABSENT
Method: Microscopy
Page No: 6 of 7
.
Booking Time 15:59:36
Sample Drawn: 30/09/2024 17:15:27
Sample Received: 30/09/2024 17:15:28
Print Date & Time: 02/10/2024 15:25:11
Date: 30/09/2024 Patient ID: 102459186 Refd by Lab:
Name : MRS. SONAM MAYANK JAIN Age : Sex: Female
Ref. By: WOMENS HOSPITAL
Sample Type: Urine,SERUM,EDTA,Flouride Random
Investigation : C.B.C.,COLLECTION,HbA1C,SUGAR RANDOM,TSH,URINE R/E
Test Name Value Unit Biological Ref Interval
OTHERS NIL NIL
Method: Microscopy
**** End Of Report ****
Page No: 7 of 7
.
